PCVX: Vaxcyte, Inc.
About
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Current Value
$86.861 Year Return
Current Value
$86.861 Year Return
Key Details
Market Cap
$10.85B
P/E Ratio
-18.61
1Y Stock Return
71.55%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
3.2
Strategies that include PCVX
Stock's related to PCVX
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SOC | 53.66% | $1.93B | +74.70% | 0.00% |
| SHLS | 32.91% | $691.80M | -70.53% | 0.00% |
| DNLI | 32.28% | $3.50B | +33.66% | 0.00% |
| KROS | 32.25% | $2.17B | +73.87% | 0.00% |
| FOLD | 31.59% | $2.84B | -11.52% | 0.00% |
| SNDX | 30.05% | $1.35B | +2.87% | 0.00% |
| PLRX | 29.00% | $778.32M | -9.55% | 0.00% |
| BBIO | 28.21% | $4.26B | -20.38% | 0.00% |
| VIV | 27.51% | $14.69B | -9.96% | 0.00% |
| TAP | 27.49% | $12.53B | +2.00% | 2.85% |
| ABUS | 27.28% | $661.33M | +90.71% | 0.00% |
| STOK | 27.05% | $614.95M | +197.69% | 0.00% |
| RCKT | 26.66% | $1.20B | -39.83% | 0.00% |
| SO | 26.51% | $96.74B | +26.76% | 3.24% |
| TVTX | 26.28% | $1.51B | +207.79% | 0.00% |
| SUI | 26.00% | $16.13B | +2.58% | 2.98% |
| ACET | 25.86% | $84.87M | -10.43% | 0.00% |
| NTST | 25.74% | $1.30B | +2.31% | 5.22% |
| ACLX | 25.42% | $4.74B | +69.19% | 0.00% |
| FR | 25.30% | $7.01B | +17.57% | 2.72% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| UPLD | <0.01% | $87.26M | -26.39% | 0.00% |
| BKNG | -0.02% | $164.72B | +58.25% | 0.53% |
| JCI | 0.03% | $55.80B | +59.01% | 1.77% |
| ROAD | -0.04% | $4.91B | +118.93% | 0.00% |
| QD | 0.04% | $335.92M | +42.44% | 0.00% |
| R | -0.05% | $6.74B | +49.22% | 1.91% |
| SWI | 0.05% | $2.22B | +22.97% | 0.00% |
| OBDC | -0.06% | $5.86B | +4.58% | 10.23% |
| PRDO | -0.07% | $1.73B | +56.77% | 1.74% |
| SF | -0.08% | $11.58B | +83.88% | 1.43% |
| ACMR | -0.08% | $1.15B | +5.14% | 0.00% |
| CLLS | -0.09% | $141.30M | -30.99% | 0.00% |
| MGPI | -0.11% | $1.02B | -48.95% | 1.04% |
| EG | -0.11% | $15.92B | -8.98% | 2.02% |
| NBR | 0.11% | $694.91M | -21.77% | 0.00% |
| TITN | 0.11% | $323.79M | -47.25% | 0.00% |
| MRVL | -0.12% | $77.39B | +63.39% | 0.27% |
| TM | 0.14% | $230.63B | -4.27% | 1.64% |
| EFR | -0.14% | $1.42B | -14.34% | 0.00% |
| ACM | -0.14% | $14.59B | +25.28% | 0.81% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| EOG | -17.34% | $76.03B | +10.19% | 2.70% |
| COP | -17.29% | $130.16B | -1.63% | 2.59% |
| EME | -16.97% | $23.65B | +140.34% | 0.18% |
| KGS | -16.41% | $3.37B | +110.22% | 4.11% |
| HUSA | -15.84% | $16.69M | -11.56% | 0.00% |
| HAL | -15.30% | $26.77B | -20.26% | 2.20% |
| VET | -15.20% | $1.57B | -21.53% | 3.35% |
| SHEL | -14.75% | $205.19B | -1.07% | 4.20% |
| MTDR | -14.57% | $7.21B | -1.21% | 1.47% |
| GTE | -13.99% | $225.69M | -1.28% | 0.00% |
| MGY | -13.89% | $5.36B | +26.87% | 1.90% |
| EXE | -13.74% | $22.11B | +17.37% | 2.39% |
| MRO | -13.72% | $16.08B | +13.59% | 1.53% |
| WTI | -13.10% | $291.77M | -42.77% | 2.01% |
| EA | -12.92% | $43.57B | +22.10% | 0.46% |
| GRAL | -12.87% | $459.22M | -13.00% | 0.00% |
| TTE | -12.77% | $138.45B | -11.95% | 5.50% |
| EQNR | -12.76% | $64.72B | -22.63% | 5.56% |
| PRT | -12.66% | $48.72M | -16.56% | 10.33% |
| SU | -12.57% | $52.05B | +23.58% | 3.92% |
ETF's related to PCVX
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 35.55% | $6.58B | 0.35% |
| IBB | 31.61% | $6.66B | 0.45% |
| FHLC | 30.44% | $2.73B | 0.084% |
| PTH | 29.84% | $143.31M | 0.6% |
| VHT | 29.54% | $17.06B | 0.1% |
| IYH | 27.90% | $3.19B | 0.39% |
| PINK | 27.63% | $161.15M | 0.5% |
| XLV | 27.48% | $38.41B | 0.09% |
| GNOM | 27.25% | $70.59M | 0.5% |
| GCOR | 26.81% | $393.53M | 0.14% |
| SPRE | 26.49% | $154.49M | 0.55% |
| PBE | 26.00% | $258.53M | 0.58% |
| UBND | 25.79% | $497.10M | 0.4% |
| XHE | 25.79% | $213.41M | 0.35% |
| XPH | 25.67% | $157.87M | 0.35% |
| TLTW | 25.66% | $1.09B | 0.35% |
| IHI | 25.66% | $4.91B | 0.4% |
| BBH | 25.62% | $397.87M | 0.35% |
| HYMB | 25.34% | $2.81B | 0.35% |
| FMHI | 25.16% | $747.15M | 0.7% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| FTEC | 0.29% | $12.59B | 0.084% |
| FTLS | 0.40% | $1.62B | 1.46% |
| PHDG | 0.43% | $113.97M | 0.39% |
| PPA | 0.49% | $4.62B | 0.57% |
| UNG | 0.52% | $908.80M | 1.06% |
| FLRT | -0.54% | $401.26M | 0.6% |
| VGT | 0.61% | $80.62B | 0.1% |
| BSCO | 0.72% | $2.35B | 0.1% |
| CPER | -0.78% | $159.52M | 0.97% |
| IBTE | 0.80% | $1.70B | 0.07% |
| IYW | -0.83% | $19.23B | 0.39% |
| CORN | 0.86% | $61.12M | 0.2% |
| DBMF | -0.86% | $1.02B | 0.85% |
| QYLD | 0.88% | $8.25B | 0.61% |
| COPX | 0.99% | $2.40B | 0.65% |
| TBLL | 1.00% | $1.92B | 0.08% |
| FTXL | -1.19% | $1.31B | 0.6% |
| GBIL | 1.29% | $5.60B | 0.12% |
| VIXY | -1.29% | $195.31M | 0.85% |
| URA | 1.35% | $3.55B | 0.69% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| DBE | -20.55% | $50.13M | 0.77% |
| CCOR | -19.63% | $109.04M | 1.18% |
| DBO | -18.12% | $217.57M | 0.77% |
| GSG | -16.87% | $914.42M | 0.75% |
| COMT | -16.14% | $829.06M | 0.48% |
| PDBC | -15.27% | $4.40B | 0.59% |
| USCI | -15.12% | $185.47M | 1.07% |
| DBC | -13.90% | $1.39B | 0.87% |
| BTAL | -12.83% | $388.04M | 1.43% |
| IEO | -12.82% | $658.25M | 0.4% |
| TPMN | -12.51% | $40.60M | 0.65% |
| IXC | -12.01% | $2.20B | 0.41% |
| UUP | -11.72% | $309.25M | 0.77% |
| VDE | -11.55% | $8.33B | 0.1% |
| USDU | -11.54% | $201.97M | 0.5% |
| XLE | -11.35% | $37.90B | 0.09% |
| FENY | -11.32% | $1.64B | 0.084% |
| IYE | -11.21% | $1.35B | 0.39% |
| DBA | -11.16% | $755.88M | 0.93% |
| EQLS | -11.14% | $76.08M | 1% |
News
SeekingAlpha
Following underperformance in Q2 2024, the Franklin Biotechnology Discovery Fund returned to strength in Q3 2024. Click here to read the full commentary.
SeekingAlpha
BlackRock Advantage Small Cap Growth Fund posted returns of 8.96% (I) for the third quarter of 2024. Click here to read the full commentary.
SeekingAlpha
For Q3 2024, the Fidelity Select Health Care Portfolio fund gained 9.48%, outperforming the MSCI sector index. Click here to read the full commentary.
SeekingAlpha
For the quarter, Fidelity Small Cap Growth Fund's Retail Class shares gained 8.48%, slightly outpacing the 8.41% advance of the benchmark Index. Click here to read more.
Yahoo
-- VAX-31 Infant Indication: Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 -- -- VAX-31 Adult Indication: Breakthrough Therapy Designation Granted by FDA; Company Plans to Initiate Adult Phase 3 Pivotal, Non-Inferiority Study by Mid-2025 -- -- VAX-31, Designed to Cover Currently Circulating and Historically Prevalent Strains, is Being Studied for the Prevention of Invasive Pneumococcal Disease in the Pediat
Yahoo
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.